GlucoSentient

company

About

GlucoSentient, a healthcare technology company, develops a personal glucose meter that allows diabetics to detect food contaminants.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$179.99K
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2011
Number Of Employee
1 - 10
Operating Status
Active

GlucoSentient, Inc. develops personal glucose meters for diabetes patients around the globe. The company offers its products for therapeutic drug and heart health monitoring applications. It also offers test strips for detecting trace amounts of contaminates, such as bacteria, viruses, or chemical contamination in food. GlucoSentient, Inc. was incorporated in 2011 and is based in Champaign, Illinois.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.07M
GlucoSentient has raised a total of $1.07M in funding over 2 rounds. Their latest funding was raised on Sep 16, 2013 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 16, 2013 Grant $0.90M 1 National Science Foundation Detail
Jun 1, 2012 Grant $179.99K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
GlucoSentient is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant